Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Link
https://link.springer.com/content/pdf/10.1007/s40262-021-01088-w.pdf
Reference50 articles.
1. Leighton A, Gottlieb AB, Dorr MB, Jabes D, Mosconi G, VanSaders C, et al. Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers. Antimicrob Agents Chemother. 2004;48:940–5.
2. Dalbavancin [package insert]. Chicago, IL: Durata Therapeutics.
3. Dunne MW, Puttagunta S, Giordano P, Krievins D, Zelasky M, Baldassarre J. A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection. Clin Infect Dis. 2016;62:545–51.
4. Rappo U, Gonzalez PL, Puttagunta S, Akinapelli K, Keyloun K, Gillard P, et al. Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections. J Glob Antimicrob Resist. 2019;17:60–5.
5. Rappo U, Puttagunta S, Shevchenko V, Shevchenko A, Jandourek A, Gonzalez PL, et al. Dalbavancin for the treatment of osteomyelitis in adult patients: a randomized clinical trial of efficacy and safety. Open Forum Infect Dis. 2018;6(1):ofy3319. https://academic.oup.com/ofid/article/6/1/ofy331/5235615. Accessed 3 Jun 2019.
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections;Clinical Pharmacokinetics;2024-08-22
2. Cell-wall-anchored proteins affect invasive host colonization and biofilm formation in Staphylococcus aureus;Microbiological Research;2024-08
3. Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview;Global and Regional Health Technology Assessment;2024-07-29
4. Usefulness of dalbavancin in early discharge and non-hospitalization. It’s time to throw your heart over the obstacle?;Global and Regional Health Technology Assessment;2024-07-29
5. Enteroccocus and Endocarditis;Infectious Diseases;2024-06-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3